Ind Swift Ltd
NSE:INDSWFTLTD
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Greenply Industries Ltd
NSE:GREENPLY
|
IN |
Ind Swift Ltd
Cash from Financing Activities
Ind Swift Ltd
Cash from Financing Activities Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cash from Financing Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Ind Swift Ltd
NSE:INDSWFTLTD
|
Cash from Financing Activities
-₹420.8m
|
CAGR 3-Years
8%
|
CAGR 5-Years
-26%
|
CAGR 10-Years
7%
|
|
|
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
|
Cash from Financing Activities
-₹13.3B
|
CAGR 3-Years
14%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
|
Cipla Ltd
NSE:CIPLA
|
Cash from Financing Activities
-₹14.3B
|
CAGR 3-Years
-16%
|
CAGR 5-Years
-5%
|
CAGR 10-Years
N/A
|
|
|
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
|
Cash from Financing Activities
-₹17.5B
|
CAGR 3-Years
-25%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Lupin Ltd
NSE:LUPIN
|
Cash from Financing Activities
₹14.5B
|
CAGR 3-Years
103%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
|
T
|
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
|
Cash from Financing Activities
-₹19.1B
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
N/A
|
|
Ind Swift Ltd
Glance View
Ind-Swift Ltd. engages in the research, development, and commercialization of pharmaceutical products. The company is headquartered in Chandigarh, Chandigarh. The firm operates in both domestic and export markets. The company is primarily engaged in the finished goods dosage and active pharmaceutical ingredients (APIs) and herbal products. The firm is also engaged in the hand sanitizer, face mask and personal protective equipment (PPE) kit market. The company operates through various divisions, such as Herba Plus Division, Noble Division, Nova Division, Ethical Division, Generic Division, Institution Division and Proposed Division. Its Herba Plus Division is engaged in the manufacturing of ayurvedic and pharmaceutical products, such as general category formulations, beta lactam, steroids and hormones, cephalosporins, oncological, soft gelatin capsules, and herbal and nutraceuticals. Its Noble Division produces various products, such as Zoxiclav, Glypar, Olmiswif, Telhim, Ozodom-DSR, Cefextil-O, Swiclo-Sp, Swifix-O, Swifix 200, Stemin and Stemin Forte.
See Also
What is Ind Swift Ltd's Cash from Financing Activities?
Cash from Financing Activities
-420.8m
INR
Based on the financial report for Mar 31, 2024, Ind Swift Ltd's Cash from Financing Activities amounts to -420.8m INR.
What is Ind Swift Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 10Y
7%
Over the last year, the Cash from Financing Activities growth was 10%. The average annual Cash from Financing Activities growth rates for Ind Swift Ltd have been 8% over the past three years , -26% over the past five years , and 7% over the past ten years .
